Heat Biologics, Inc.
Heat Biologics, Inc. (HTBX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · HTBX · as of Dec 31, 2024
Ownership Breakdown
1
Institutional Holders
$1
Total Inst. Value
25.66M
Shares Outstanding
freeFloat 94.53%
1
13F Shares Held
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
HTBX largest shareholders · institutional ownership
Q4 2024 · SEC 13F
Showing top 1 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
HUNTINGTON NATIONAL BANK pharmaceutical preparations | 1 | 0.00% | 0.00% | $1,000 | Feb 12, 2025 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q4 2024 vs prior quarter
Q4 2024
0
Increased
+0 shares0
New Positions
first time holders0
Decreased
−0 shares0
Sold Out
fully exitedNet shares change (top 50)
+0
+0 / −0
Net new holders
+0
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
HTBX insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Smith Edward B III director | Dec 30, 2021 | Award | 32,467 | $4.06 | $131.8K | 32.5K | Form 4 ↗ |
Smith Edward B III director | Dec 30, 2021 | J-Other | 32,467 | $4.06 | $131.8K | 0 | Form 4 ↗ |
Smith Edward B III director | Dec 13, 2021 | Award | 32,467 | $4.06 | $131.8K | 32.5K | Form 4 ↗ |
Ostrander William L. CFO/Corp Secy | Dec 13, 2021 | Award | 68,807 | $4.06 | $279.4K | 68.8K | Form 4 ↗ |
Smith Edward B III director | Jan 4, 2021 | Award | 65,217 | $5.67 | $369.8K | 65.2K | Form 4 ↗ |
Ostrander William L. CFO/Corp Secy | Jan 4, 2021 | Award | 51,487 | $5.67 | $291.9K | 51.5K | Form 4 ↗ |
Smith Edward B III director | Nov 12, 2020 | Sale | 103,304 | $1.03 | $106.4K | 0 | Form 4 ↗ |
Ostrander William L. VP Finance/Corp Secy | Aug 13, 2020 | Tax Withhold | 4,440 | $1.83 | $8.1K | 11.2K | Form 4 ↗ |
Ostrander William L. VP Finance/Corp Secy | Mar 12, 2020 | Award | 150,000 | $0.60 | $90.0K | 150.0K | Form 4 ↗ |
Smith Edward B III director | Jan 2, 2020 | Award | 150,000 | $0.46 | $69.6K | 150.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Heat Biologics, Inc. (HTBX) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 5.47%, while retail and public investors account for the remaining 94.53%.
The largest institutional shareholder of Heat Biologics, Inc. is HUNTINGTON NATIONAL BANK, holding approximately 1 shares — equal to — of outstanding shares — as of December 31, 2024.
A total of 1 institutional investors currently hold HTBX stock, with a combined institutional value of approximately $1 as of the most recent 13F filing period.
Frequently asked questions
HTBX ownershipHeat Biologics, Inc. (HTBX) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is HUNTINGTON NATIONAL BANK with a — stake. Company insiders hold 5.47%. Data sourced from SEC Form 13F as of December 31, 2024.